FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387265087> ?p ?o ?g. }

• W4387265087 endingPage "4239" @default.
• W4387265087 startingPage "4239" @default.
• W4387265087 abstract "Dyslipidemia, a condition implying high cardiovascular risks, has been widely studied on its potential nutrition interventions, including functional foods. This study aims to examine the effect of nattokinase monascus supplements (NMSs) on cardiovascular biomarkers and carotid intima-media thickness (CIMT) in patients with dyslipidemia. A total of 113 eligible subjects were randomly assigned to receive either NMSs or a placebo (55 and 58, respectively). After a 120-day intervention, there were significant mean absolute changes in total cholesterol (TC), low-density cholesterol (LDL-C), non-high-density cholesterol (non-HDL-C), and low-density cholesterol to high-density cholesterol ratio (LDL-C to HDL-C ratio), with values of -0.52 (95% CI: -0.51 to -0.54) mmol/L, -0.43 (95% CI: -0.45 to -0.41) mmol/L, -0.52 (95% CI: -0.52 to -0.52) mmol/L, and -0.29 (95% CI: -0.30 to -0.28) mmol/L, respectively, between the two groups. However, no significant differences were found in triglycerides (TGs), high-density cholesterol (HDL-C), and CIMT. Furthermore, the results for lipids and CIMT remained essentially unchanged after adjusting for various confounding factors using the analysis of covariance model. There were no significant differences in coagulation, liver function, renal function, or other indicators. No intervention-related adverse events, such as mouth ulcers, drooling, and stomach pain, were reported. The study results demonstrate that NMSs can ameliorate lipid levels (TC, LDL-C, non-HDL-C, and the LDL-C to HDL-C ratio) without the occurrence of adverse events. However, it did not significantly affect serum TG, HDL-C, and CIMT." @default.
• W4387265087 created "2023-10-03" @default.
• W4387265087 creator A5010965849 @default.
• W4387265087 creator A5026329951 @default.
• W4387265087 creator A5042427117 @default.
• W4387265087 creator A5044524054 @default.
• W4387265087 creator A5045205212 @default.
• W4387265087 creator A5052304130 @default.
• W4387265087 creator A5056674934 @default.
• W4387265087 creator A5062181450 @default.
• W4387265087 creator A5075706011 @default.
• W4387265087 creator A5076992572 @default.
• W4387265087 creator A5077870160 @default.
• W4387265087 creator A5091432366 @default.
• W4387265087 date "2023-09-30" @default.
• W4387265087 modified "2023-10-18" @default.
• W4387265087 title "The Effect of Nattokinase-Monascus Supplements on Dyslipidemia: A Four-Month Randomized, Double-Blind, Placebo-Controlled Clinical Trial" @default.
• W4387265087 cites W1973557710 @default.
• W4387265087 cites W1983384986 @default.
• W4387265087 cites W1988724742 @default.
• W4387265087 cites W1998254400 @default.
• W4387265087 cites W2067614264 @default.
• W4387265087 cites W2085144467 @default.
• W4387265087 cites W2113174543 @default.
• W4387265087 cites W2156317766 @default.
• W4387265087 cites W2161168306 @default.
• W4387265087 cites W2167949935 @default.
• W4387265087 cites W2180384554 @default.
• W4387265087 cites W2273474388 @default.
• W4387265087 cites W2416821331 @default.
• W4387265087 cites W2465758073 @default.
• W4387265087 cites W2509676484 @default.
• W4387265087 cites W2619972390 @default.
• W4387265087 cites W2806841577 @default.
• W4387265087 cites W2809654982 @default.
• W4387265087 cites W2886607778 @default.
• W4387265087 cites W2898998405 @default.
• W4387265087 cites W2900034165 @default.
• W4387265087 cites W2920986786 @default.
• W4387265087 cites W2924007167 @default.
• W4387265087 cites W2925038998 @default.
• W4387265087 cites W2980738803 @default.
• W4387265087 cites W3043910493 @default.
• W4387265087 cites W3126288346 @default.
• W4387265087 cites W3152434583 @default.
• W4387265087 cites W3208063557 @default.
• W4387265087 cites W4207037927 @default.
• W4387265087 cites W4220965411 @default.
• W4387265087 cites W4225007586 @default.
• W4387265087 doi "https://doi.org/10.3390/nu15194239" @default.
• W4387265087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37836525" @default.
• W4387265087 hasPublicationYear "2023" @default.
• W4387265087 type Work @default.
• W4387265087 citedByCount "0" @default.
• W4387265087 crossrefType "journal-article" @default.
• W4387265087 hasAuthorship W4387265087A5010965849 @default.
• W4387265087 hasAuthorship W4387265087A5026329951 @default.
• W4387265087 hasAuthorship W4387265087A5042427117 @default.
• W4387265087 hasAuthorship W4387265087A5044524054 @default.
• W4387265087 hasAuthorship W4387265087A5045205212 @default.
• W4387265087 hasAuthorship W4387265087A5052304130 @default.
• W4387265087 hasAuthorship W4387265087A5056674934 @default.
• W4387265087 hasAuthorship W4387265087A5062181450 @default.
• W4387265087 hasAuthorship W4387265087A5075706011 @default.
• W4387265087 hasAuthorship W4387265087A5076992572 @default.
• W4387265087 hasAuthorship W4387265087A5077870160 @default.
• W4387265087 hasAuthorship W4387265087A5091432366 @default.
• W4387265087 hasBestOaLocation W43872650871 @default.
• W4387265087 hasConcept C126322002 @default.
• W4387265087 hasConcept C134018914 @default.
• W4387265087 hasConcept C142724271 @default.
• W4387265087 hasConcept C168563851 @default.
• W4387265087 hasConcept C197934379 @default.
• W4387265087 hasConcept C204787440 @default.
• W4387265087 hasConcept C27081682 @default.
• W4387265087 hasConcept C2778096610 @default.
• W4387265087 hasConcept C2778163477 @default.
• W4387265087 hasConcept C2778913445 @default.
• W4387265087 hasConcept C2780541478 @default.
• W4387265087 hasConcept C511355011 @default.
• W4387265087 hasConcept C71924100 @default.
• W4387265087 hasConcept C90924648 @default.
• W4387265087 hasConceptScore W4387265087C126322002 @default.
• W4387265087 hasConceptScore W4387265087C134018914 @default.
• W4387265087 hasConceptScore W4387265087C142724271 @default.
• W4387265087 hasConceptScore W4387265087C168563851 @default.
• W4387265087 hasConceptScore W4387265087C197934379 @default.
• W4387265087 hasConceptScore W4387265087C204787440 @default.
• W4387265087 hasConceptScore W4387265087C27081682 @default.
• W4387265087 hasConceptScore W4387265087C2778096610 @default.
• W4387265087 hasConceptScore W4387265087C2778163477 @default.
• W4387265087 hasConceptScore W4387265087C2778913445 @default.
• W4387265087 hasConceptScore W4387265087C2780541478 @default.
• W4387265087 hasConceptScore W4387265087C511355011 @default.
• W4387265087 hasConceptScore W4387265087C71924100 @default.
• W4387265087 hasConceptScore W4387265087C90924648 @default.
• W4387265087 hasIssue "19" @default.
• W4387265087 hasLocation W43872650871 @default.

• next